Inventaire - your friends and communities are your best library

Drug metabolome of the simvastatin formed by human intestinal microbiota in vitro

Author

Matej Orešič

1967 -

Peddinti V. Gopalacharyulu

Kirsi-Marja Oksman-Caldentey

Tuulia Hyötyläinen

Ismo Mattila

Anna-Marja Aura

published in: Molecular BioSystems

date of publication: 2010-11-08

main subject: (R)-2-hydroxyisovaleric acid, Simvastatina

Bibliographic databases:

Cites articles 42

Date

Title

Authors

1971-01-01

Degradation of DOPA by intestinal microorganisms in vitro,Degradation of DOPA by Intestinal Microorganisms in Vitro
1974-11-01

Metabolism of drugs by microorganisms in the intestine
1976-01-01

Biliary excretion of mestranol in the female rat: effect of neomycin pretreatment on enterohepatic recirculation
1984-05-01

Conjugation of 1-naphthol by human colon and tumour tissue using different experimental systems
1986-10-01

The role of intestinal flora in metabolism of phenolic sulfate esters
1988-01-01

Interactions of the gut microflora and the host in toxicology
1989-06-01

Estimation of phenolic conjugation by colonic mucosa
1990-02-01

Intestinal microflora: metabolism of drugs and carcinogens
1992-02-01

Isolation of human colonic crypts for study of xenobiotics metabolism
1992-01-01

Comparison of fermentation reactions in different regions of the human colon
1992-04-01

Sulfation of phenolic antibiotics by sulfotransferase obtained from a human intestinal bacterium
1995-11-16

Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group
1995-09-01

Estimation of the fermentability of dietary fibre in vitro: a European interlaboratory study
1996-10-03

The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators
1997-04-01

Formation of Phenolic and Indolic Compounds by Anaerobic Bacteria in the Human Large Intestine
1997-05-01

Biotransformation of (-)-epicatechin 3-O-gallate by human intestinal bacteria
1998-08-01

Functional food science and gastrointestinal physiology and function.
2000-11-01

Polymeric proanthocyanidins are catabolized by human colonic microflora into low-molecular-weight phenolic acids
2002-03-01

Use of oral antimicrobials decreases serum enterolactone concentration
2002-05-01

Glucuronidation of statins in animals and humans: a novel mechanism of statin lactonization
2002-03-01

Structural characterization of in vivo rat glutathione adducts and a hydroxylated metabolite of simvastatin hydroxy acid
2002-03-01

Quercetin derivatives are deconjugated and converted to hydroxyphenylacetic acids but not methylated by human fecal flora in vitro
2002-01-01

Enterohepatic circulation: physiological, pharmacokinetic and clinical implications
2002-08

A direct approach to false discovery rates
2004-04-28

In vitro metabolism of anthocyanins by human gut microflora

, ,
2004-01-01

Colonic metabolism of dietary polyphenols: influence of structure on microbial fermentation products
2004-10-01

Intake of whole grains and vegetables determines the plasma enterolactone concentration of Danish women

, ,
2005-02-01

Chemical, pharmacokinetic and pharmacodynamic properties of statins: an update
2005-09-01

Metabolism of anthocyanins and their phenolic degradation products by the intestinal microflora
2005-04-25

Suitability of a batch in vitro fermentation model using human faecal microbiota for prediction of conversion of flaxseed lignans to enterolactone with reference to an in vivo rat model
2005-12-01

Statin-induced myositis: a commonly encountered or rare side effect?
2006-12-20

A systems biology strategy reveals biological pathways and plasma biomarker candidates for potentially toxic statin-induced changes in muscle

, , , ,

Article -

Welcome to inventaire

The library of your friends and communities

Learn more